The Actual Product Strain BP-412 of Beni-Koji Choleste Help Was Not Used in Co-Culture Testing — The Issue of an Industrial Mutant Strain Recognizable by Authorities —
NQ Score
49/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Kunsei Club Co., Ltd. has filed a formal objection to the Yoshinari paper (Yoshinari et al., 2025) published by the National Institute of Health Sciences (NIHS), pointing out that the co-culture experiment used NBRC 4520, the parent strain, instead of BP-412—the industrial mutant strain actually used in the product. The company demands scientific re-evaluation due to concerns over validity and transparency.
AI Analysis
Frequently Asked Questions
- Q: What is the issue with Kobayashi Pharmaceutical's red yeast rice supplement?
- A: Health incidents have occurred, raising demands for scientific verification of the cause.
- Q: Which strain was used in the NIHS experiment?
- A: NBRC 4520, the parent strain, not BP-412 used in the actual product.
- Q: Why is using a different strain problematic?
- A: Genetic differences may alter metabolites, invalidating causal conclusions for the real product.
- Q: What kind of company is Kunsei Club?
- A: A food manufacturer in Okayama led by a pharmacist, emphasizing scientific transparency.
- Q: What is expected to happen next?
- A: Additional data disclosure and retesting with BP-412 are likely to be demanded.